logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.

date
21:11 17/01/2025
avatar
GMT Eight
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
New stock news | Guangdong Topstar Technology (300607.SZ) submits application to Hong Kong Stock Exchange
New Stock News | Wenshi Information Submitted to the Hong Kong Stock Exchange
New stock news | Qin Hao Pharmaceuticals submits application to Hong Kong Stock Exchange.
New stock news | Guangdong Topstar Technology (300607.SZ) submits application to Hong Kong Stock Exchange
New Stock News | Wenshi Information Submitted to the Hong Kong Stock Exchange
New stock news | Qin Hao Pharmaceuticals submits application to Hong Kong Stock Exchange.
RECOMMEND
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
icon
14/01/2026
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
icon
14/01/2026
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
icon
14/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.